ASTH — Astrana Health Balance Sheet
0.000.00%
- $1.60bn
- $1.44bn
- $2.03bn
- 77
- 65
- 23
- 56
Annual balance sheet for Astrana Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-Q | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 261 | 287 | 294 | 296 | 291 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 60.7 | 93.6 | 120 | 148 | 325 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 339 | 399 | 428 | 462 | 638 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 48.5 | 69.9 | 129 | 44.6 | 46.9 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 817 | 852 | 966 | 933 | 1,355 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 115 | 115 | 149 | 219 | 366 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 487 | 398 | 424 | 319 | 642 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 331 | 455 | 543 | 614 | 713 |
| Total Liabilities & Shareholders' Equity | 817 | 852 | 966 | 933 | 1,355 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |